Monoclonal Antibodies Market Set for Rapid Growth

1
Monoclonal Antibodies Market Global Analysis and
Forecast to 2028

• Published Date May 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Monoclonal Antibodies Market Forecast to 2028 -
  COVID-19 Impact and Global Analysis By Source
  (Human, Humanized, Chimeric, and Murine),
  Production Method (In-Vitro and In-Vivo),
  Indication (Cancer, Autoimmune Diseases,
  Infectious Diseases, Inflammatory Diseases,
  Microbial Diseases, and Others), Application
  (Therapeutic Applications, Diagnostic
  Applications, and Research Applications), and
  End-User (Hospitals, Others, and Research
  Institutes)
• The monoclonal antibodies market is projected to
  reach US 243.05 billion by 2028 from US 111.01
  billion in 2021 it is expected to grow at a CAGR
  of 11.8 from 2021 to 2028.

3
Monoclonal Antibodies Market Overview
Email sales_at_theinsightpartners.com

• The report highlights the key factors driving the
  market growth and prominent players with their
  developments in the market Based on indication,
  the monoclonal antibodies market is segmented
  into cancer, autoimmune diseases, infectious
  diseases, inflammatory diseases, microbial
  diseases, and others. The cancer segment is
  likely to account for a large market share during
  20212028.
• By source, the monoclonal antibodies market is
  segmented into human, humanized, chimeric, and
  murine. The human segment held a considerable
  share of the market in 2021 and is likely to
  continue its dominance in the market during the
  forecast period. The preventive administration of
  "palivizumab" human mAB proves effective against
  severe respiratory diseases that pose a high risk
  in infants and immunocompromised adults it is
  the only mAB product licensed against infectious
  diseases.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment By Type-
• By Source (Human, Humanized, Chimeric, and
  Murine)
• Production Method (In-Vitro and In-Vivo)
• Indication (Cancer, Autoimmune Diseases,
  Infectious Diseases, Inflammatory Diseases,
  Microbial Diseases, and Others)
• Application (Therapeutic Applications, Diagnostic
  Applications, and Research Applications)
• End-User (Hospitals, Others, and Research
  Institutes)

Download Sample Here
5
Monoclonal Antibodies Market Value
Email sales_at_theinsightpartners.com

• CAGR of 11.8
• (2021 - 2028)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com

• Novartis AG
• Pfizer Inc.
• GlaxoSmithKline plc
• Amgen, Inc
• Daiichi Sankyo Company, Limited
• F. Hoffmann-La Roche AG
• AstraZeneca
• Elli Lily and Company
• Bayer AG
• Bristol-Myers Squibb Company

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com